DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹2.00 Cr | - | - | - | ₹0.35 Cr |
What is the latest Total Debt ratio of DIVIS LABORATORIES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹2.00 Cr |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | ₹0.35 Cr |
How is Total Debt of DIVIS LABORATORIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.00 Cr | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | -100.00 | |
| Mar2021 | ₹0.35 Cr | - | |
Compare Total Debt of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹175,082.6 Cr | -3.3% | -0.7% | -1.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,926.0 Cr | -3% | -1.9% | 7.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,806.0 Cr | -3.8% | 2.8% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,910.0 Cr | -3% | 3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,755.0 Cr | -4.3% | -2% | 2.5% | Stock Analytics | |
| MANKIND PHARMA | ₹97,215.3 Cr | -2% | 4.9% | -7.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -3.3% |
-0.7% |
-1.6% |
| SENSEX | -2% |
-3.8% |
-8.6% |
You may also like the below Video Courses